Question 1

What are the key details for the project “Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)”?

Accepted Answer

The project “Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)” is an infrastructure initiative in the Government sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Question 2

What is the latest status of the project “Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)”?

Accepted Answer

The status recorded for “Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)” is archived.

Question 3

Who are the main government, EPC, and private stakeholders for “Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)”?

Accepted Answer

Taiyo maps the stakeholders of “Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)”: government bodies (National Institutes of Health (NIH), US Department of Health and Human Services (HHS), US Government).

Question 4

Where can I verify the source and access all details for “Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)”?

Accepted Answer

This Taiyo project page references Grants.gov along with the original URL (https://www.grants.gov/web/grants/view-opportunity.html?oppId=292853). Taiyo standardizes official data into a consistent, searchable project profile.

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Original status	archived
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description	The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes within the National Institutes of Health (NIH) encourage small business SBIR grant applications to address different and complementary research needs for the development of appropriate pediatric drug formulations in different age groups. This FOA also encourages the development and testing of novel drug delivery systems in the pediatric population. The goal of this FOA is to complement and accelerate the development of appropriate pediatric drugs formulations and drug delivery systems.
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)

Project Information FAQ

Project Information